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We have developed a sensitive microscale binding assay to study the interaction between influenza hemagglutinin and
its cell surface receptor sialic acid using real-time surface plasmon resonance. The glycoprotein fetuin was bound to a
carboxymethylated-Dextran sensor surface using N-hydroxysuccinimide and N-ethyl-N*-(dimethylaminopropyl) carbodiimide.
Low-pH-induced BHA rosettes bind specifically to the fetuin-derivitized sensor surface, but not to an asialofetuin-derivitized
sensor surface. Binding can be inhibited by preincubation of BHA rosettes with millimolar concentrations of inhibitors of
the influenza hemagglutinin–sialic acid interaction. The association rate, dissociation rate, and dissociation constant for
the multivalent interaction between BHA rosettes and the fetuin-derivitized sensor surface were also measured, allowing
us to quantitate the tight binding achieved through the multivalent interaction between BHA rosettes and the fetuin-derivitized
sensor surface. q 1996 Academic Press, Inc.
INTRODUCTION modifications have included potassium periodate oxida-
tion (Underwood et al., 1987) and replacement of the
Influenza virus hemagglutinin is responsible for bind- native sialic acid with sialic acid in exclusively a2-3 or
ing virus to target cells by recognizing membrane recep- a2-6 linkages (Carroll et al., 1981) or sialic acid ana-
tor molecules containing sialic acid (review, Wiley and logues (Higa et al., 1985). Hemagglutination inhibition
Skehel, 1987). X-ray crystallographic studies have re- studies have also been done using sialic acid analogues
vealed that the structure of the sialic acid binding site (Toogood et al., 1991; Glick et al., 1991). These studies
complexed with various sialosides (Wilson et al., 1981; are sufficient to distinguish differences in hemagglutina-
Weis et al., 1988; Sauter et al., 1992; Watowich et al., tion of a factor of 2, but usually only the relative binding
1994). The interaction between a soluble form of hemag- between influenza virus and red blood cells has been
glutinin and sialic acid has been studied using NMR measured; estimates of the association rate, dissociation
(Sauter et al., 1989, 1992) and fluorescence polarization rate, and dissociation constant for the multivalent interac-
(Weinhold and Knowles, 1992) and these studies have tion have not been possible.
found that the dissociation constant is in the millimolar The protease bromelain cleaves influenza virus hem-
range. Because these assays require milligram quanti- agglutinin near the viral membrane, releasing a soluble
ties of hemagglutinin, it is impractical to make accurate form of hemagglutinin called BHA (Brand and Skehel,
measurements of binding constants of sialic acid to site- 1972). When the pH of a BHA solution is reduced to 5,
directed binding site mutants of the influenza hemag- BHA undergoes a conformational change associated
glutinin. with membrane fusion (Skehel et al., 1982). If the low-
Although the dissociation constant for the binding of pH conformational change is induced in the absence of
hemagglutinin to sialic acid is in the millimolar range, detergent, the BHA trimers form soluble aggregates
influenza virus is capable of tight binding to the cells it called rosettes, containing about 6 to 10 BHA trimers as
infects because it is capable of binding multiple sialic estimated by sucrose gradient sedimentation and elec-
acid moieties simultaneously. One consequence of this tron microscopy (Skehel et al., 1982). These rosettes are
multidentate binding is the observation that influenza vi- capable of binding sialic acid analogues with approxi-
rus can hemagglutinate red blood cells (Hirst, 1941). mately the same affinity as BHA, as measured by NMR
Hemagglutination studies have also been done with in- (Sauter et al., 1992). Rosettes can hemagglutinate red
fluenza virus and modified erythrocytes. The specific blood cells (Skehel et al., 1982), demonstrating that they
are capable of multidentate binding characteristic of the
interaction between influenza virus and its target cell.1 To whom correspondence and reprint requests should be ad-
dressed. We have used this multidentate binding in combination
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with the sensitivity of real-time surface plasmon reso- scribed (Skehel et al., 1982). To remove residual neur-
aminidase the rosettes were further purified on a 5–25%nance to develop a sensitive microscale assay for the
interaction between influenza virus hemagglutinin and sucrose gradient in HBS (10 mM HEPES, 150 mM NaCl,
3.4 mM EDTA, pH 7.5) with 0.1 mM PMSF in a SW 41its sialic acid receptor. We can demonstrate that the
binding observed is dependent on the sialic acid moiety rotor at 34,000 rpm for 16 hr at 107. Fractions (0.5 ml)
were collected and 5 ml from each fraction was analyzedand that preincubation with millimolar concentrations of
inhibitors can block binding of rosettes to the fetuin- using SDS–PAGE (Laemmli, 1970). Fractions containing
low-pH BHA rosettes (usually the bottom four or five frac-derivitized sensor surface. We have compared the bind-
ing characteristics of wild type X-31 hemagglutinin and tions) were pooled and dialyzed at least twice into HBS.
The concentration of the rosettes in solution was deter-the variant V262 to demonstrate the sensitivity and speci-
ficity of the binding assay. We have directly measured mined by OD280 .
the association rate, dissociation rate, and dissociation
constant of the interaction between rosettes and the fet- Gel filtration chromatography
uin-derivitized sensor surface, with the goal of under-
standing how tight binding of hemagglutinin and influ- Sephacryl S-500 HR resin was purchased from Phar-
macia and a 30-cm-long 1 0.6-cm-wide i.d. column wasenza viruses to cell surface receptors is achieved.
made according to the manufacturer’s instructions. Blue
Dextran, thyroglobulin, apoferritin, and b-amylase wereMATERIALS AND METHODS
purchased from Sigma Chemicals and used without fur-
Surface plasmon resonance detection system ther purification.
All binding experiments were carried out on a BIAcore
biosensor system (Pharmacia BioSensor Inc.) using a Sialic acids
carboxy-methylated Dextran-coated gold sensor surface
a(2,3)-Sialyllactose and a(2,6)-sialyllactose were pur-(CM-Dextran). The ligand is covalently immobilized to the
chased from BioCarb Chemicals and used without furtherCM-Dextran surface. A solution containing the protein of
purification. a-Methyl sialic acid was synthesized as pre-interest is then injected over the derivitized sensor sur-
viously described (Sauter et al., 1989).face. The surface plasmon resonance signal (SPR sig-
nal), given in terms of response units (RUs), is linearly
correlated with the refractive index of the solution in the Surface plasmon resonance binding experiments
immediate vicinity of the sensor surface. The SPR signal
Sucrose-gradient purified BHA rosettes were dilutedis measured before and after exposure of the surface by
in HBS to a final concentration of 100–450 mg/ml andthe protein solution. The resulting change in SPR signal
exposed to the derivitized sensor surface for 7–9 min atis linearly correlated with the amount of protein bound
a flow rate of 5 ml/min. During the dissociation phaseto the ligand (Li et al., 1981; Stenberg et al., 1991).
the sensor surface was exposed to HBS at a flow rate
of 5 ml/min. The sensor surface was regenerated usingImmobilization of ligands onto sensor surface
1 ml 200 mM NaCO3 , pH 11.5. Between binding experi-Fetuin and asialofetuin (Sigma) were used without ments the sensor surface was exposed to HBS. For bind-
further purification. The CM-Dextran sensor surface ing experiments with inhibitors the purified rosettes were
was activated using a mixture of N-hydroxysuccinimide preincubated with the inhibitor for 3–5 min on ice prior
(NHS) and N-ethyl-N*-(dimethylaminopropyl) carbodii- to injection over the sensor surface.
mide (EDC) as described (Johnsson et al., 1991). Fetuin
or asialofetuin was dissolved into a 10 mM sodium ace-
Analysis of kinetics datatate, pH 4.5, solution at 0.25–0.50 mg/ml and injected
over the activated sensor surface for 7–9 min at a flow The sensorgrams used for direct Kd measurementrate of 5 ml/min. The remaining NHS sites were blocked were analyzed on a NEC 66-MHz 486DX2 using the pro-
with a 40-ml 1.0 M ethanolamine, pH 8.0. Typically we gram BIAEvaluation2 (Pharmacia BioSensor Inc.). The
can immobilize 11,000–15,000 RUs of fetuin or asialofet- model that fit the dissociation data best was a homoge-
uin using this procedure. neous dissociation model. The model that fit the associa-
tion data best was a homogeneous association modelPreparation of low-pH BHA rosettes
which calculates Ks  KaCn / Kd and initial binding rate
r0 by fitting data to the equation R  r0/Ks(1 0 eKs(t0t0)),BHA (bromelain-released hemagglutinin) was isolated
from the recombinant influenza strains X-31 and V262 where R is the SPR signal, n is the steric interference
factor, t0 is the start time for the association, and C isas described (Brand and Skehel, 1972). Low-pH-induced
BHA rosettes were made by treatment at pH 5.0 as de- the molar concentration of the analyte.
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start of the injection due to the presence of a(2,6)-sialyl-
lactose in the solution. During the injection there is a
smaller increase in SPR signal, reflecting reduced rosette
binding in the presence of inhibitor.
The inhibition of X-31 rosette binding by a(2,6)-sialyl-
lactose was measured at inhibitor concentrations from
0.125 to 4 mM, and the results are shown in Fig. 2b. Half-
maximal competition occurs at an inhibitor concentration
of about 1.2 mM. This is similar to the Kd of 2.1 mM for
the interaction between BHA and a(2,6)-sialyllactose as
previously determined by NMR (Sauter et al., 1989). After
rosettes have been bound to the sensor surface, subse-
quent addition of 2 mM a(2,6)-sialyllactose did not signifi-
cantly reduce rosette binding. The inhibition of X-31 ro-
sette binding by a-methyl sialic acid and a(2,3)-sialyllac-
FIG. 1. 45 ml of X-31 BHA rosettes (250 mg/ml) was injected at a flow tose was also measured, and the results are summarized
rate of 5 ml/min over a CM-Dextran sensor surface with a similar
in Fig. 3a. We find that the half-maximal inhibition con-amount of fetuin (open squares) and asialofetuin (solid triangles) immo-
centration for a-methyl sialic acid is 0.8 mM and forbilized (11,000 RUs).
a(2,3)-sialyllactose is 2.4 mM. Consistent with the NMR
and hemagglutination inhibition data, a(2,6)-sialyllactose
RESULTS inhibits X-31 rosette binding more effectively than a(2,3)-
sialyllactose. Comparing the difference in half-maximalLow-pH BHA rosettes bind specifically to the fetuin-
inhibition concentration between two experiments usingderivitized CM-Dextran sensor surface
the same inhibitor (Fig. 3b), we estimate the error in the
Figure 1 demonstrates that low-pH X-31 BHA rosettes measurement of the half-maximal inhibition concentra-
bind to the fetuin-derivitized sensor surface but not to the tion to be about {20%. The difference between a(2,3)-
asialofetuin-derivitized sensor surface. When X-31 BHA ro- sialyllactose inhibition and a(2,6)-sialyllactose inhibition
settes are injected over the fetuin-derivitized sensor sur- is only slightly larger than the error in the measurements,
face, there is a rapid rise in SPR signal due to rosette so care is required in interpreting the data.
binding to the sensor surface. After the injection is com- The hemagglutinin variant V262 has a single point muta-
plete, there is a very slow decrease in SPR signal due to tion in HA1 (G135R). V262 virus is able to hemagglutinate
bound rosettes dissociating from the sensor surface. On periodate-treated red blood cells at periodate concentrations
the other hand, when X-31 rosettes are injected over the where all other strains tested failed to do so (Underwood et
asialofetuin-derivitized sensor surface, there is an immedi- al., 1987). Periodate is thought to remove the glycerol moiety
ate small increase in SPR signal due to the presence of from sialic acid. G135R BHA exhibits a lower affinity for a-
rosettes and sucrose in the solution, but no significant in- methyl sialic acid, a(2,3)-sialyllactose, and a(2,6)-sialyllac-
crease during the injection. After the injection, the SPR tose as demonstrated by NMR (Sauter et al., 1992).
signal drops to the baseline level. These observations sug- We made low-pH-induced G135R BHA rosettes and
gest that the binding between the rosettes and the fetuin tested their binding to the fetuin-derivitized sensor sur-
bound to the sensor surface is due to sialic acids on the face. G135R rosettes bind to the fetuin-derivitized sensor
fetuin. Similarly, low-pH X-31 BHA rosettes do not bind to surface about one-tenth as well as X-31 rosettes, as mea-
an activated and blocked CM-Dextran sensor surface (data sured by the concentration of X-31 or G135R rosettes
not shown), suggesting that the activated and blocked CM- required to generate the same SPR signal on the same
Dextran surface does not contribute significantly to rosette fetuin-derivitized sensor surface (data not shown). The
binding to the sensor surface. inhibition of G135R rosette binding by a(2,6)-sialyllactose
and a(2,3)-sialyllactose was measured, and the results
Inhibitors of the sialic acid–hemagglutinin interaction
are summarized in Fig. 3b. We find that a(2,6)-sialyllac-
block rosette binding to the fetuin-derivitized sensor
tose and a(2,3)-sialyllactose inhibit G135R rosette bind-
surface
ing with half-maximal inhibition concentrations of about
2.8 and 3.7 mM, respectively, which is greater than theFigure 2a shows that preincubation of X-31 rosettes
with millimolar concentrations of a(2,6)-sialyllactose corresponding values for inhibition of X-31 rosette bind-
ing. These results are consistent with the NMR resultsblocks rosette binding to the fetuin-derivitized sensor
surface. In the absence of a(2,6)-sialyllactose there is a (Table 1). However, when comparing the binding of mu-
tant hemagglutinins, identical methods of rosette prepa-rapid rise in SPR signal, just as in Fig. 1. In the presence
of a(2,6)-sialyllactose there is a larger increase at the ration may be important in order to generate the same
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FIG. 2. Inhibition of X-31 BHA rosette binding by a(2,6)-sialyllactose. (a) 35 ml of X-31 BHA rosettes (100 mg/ml) was preincubated for 3–5 min
on ice with 4 mM (solid circles), 1 mM (open circles), 0.25 mM (solid triangles), or 0 mM (open upside-down triangles) a(2,6)-sialyllactose. Then
they were injected at a flow rate of 5 ml/min over a CM-Dextran sensor surface with 14,000 RUs of fetuin immobilized. The data for 0.125 mM,
0.5 mM, and 2 mM were omitted for clarity. (b) A semilog plot of X-31 BHA rosette binding inhibition by a(2,6)-sialyllactose, given as the fraction
of rosettes bound in the presence of a(2,6)-sialyllactose compared to the rosettes bound in the absence of a(2,6)-sialyllactose.
average numbers of hemagglutinin trimers per rosette. surface, we obtained binding and dissociation curves
at different rosette concentrations. Typical results areGel filtration chromatography (Sephacryl S-500 HR) indi-
shown in Fig. 4. The association and dissociationcates that X-31 and G135R rosettes have similar elution
curves were analyzed as described under Materialsvolumes and elution profiles (data not shown) and are
and Methods using the program BIAEvaluation2 (Phar-free of aggregates, suggesting that they have a similar
macia Biosensor Inc.). We assumed that there is anaverage number of hemagglutinin trimers per rosette.
average of 8 BHA trimers per rosette, based on pre-
Determination of the Kd for the interaction between viously published estimates of 6 to 10 trimers per ro-
the fetuin-derivitized CM–Dextran sensor surface and sette (Skehel et al., 1982). Using that estimate, 200 mg/
X-31 rosettes ml of X-31 rosettes corresponds to about a 120 nM X-
To measure the equilibrium dissociation constant for 31 rosette solution. To calculate the Ka we need to
estimate the steric interference factor, the number ofbinding of X-31 rosettes to the fetuin-derivitized sensor
FIG. 3. Inhibition of BHA rosette binding by various sialosides. (a) Comparison of inhibition of X-31 BHA rosette binding by a(2,3)-sialyllactose
(crosses), a(2,6)-sialyllactose (solid triangles, solid circles), and a-methyl sialic acid (open squares, open upside-down triangles). Two trials were
performed on the a(2,6)-sialyllactose (2,6 1 and 2,6 2) and a-methyl sialic acid (aM 1 and aM 2) samples. (b) Comparison of inhibition of G135R
BHA rosette binding by a(2,3)-sialyllactose (solid circles) and a(2,6)-sialyllactose (open squares).
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TABLE 1
Inhibition of BHA Rosette Binding by Sialic Acid Analogues
Half-maximal inhibition concentration Kd from NMR
Viral strain Inhibitor (mM)a (mM)
X-31 a(2,6)-sialyllactose 1.2 { 0.2b 2.1 { 0.4c
a(2,3)-sialyllactose 2.4 { 0.5 3.2 { 0.6c
a-methyl sialic acid 0.8 { 0.2b 2.8 { 0.6c
V262 (G135R) a(2,6)-sialyllactose 2.8 { 0.6 3.7 { 0.7d
a(2,3)-sialyllactose 3.7 { 0.7 4.2 { 0.8d
Dissociation constant for binding of X31 BHA rosettes to the fetuin-bound sensor surface
Ka (M01 sec01)e Kd (sec01) Kd (nM)e
2 1 103 2 1 1004 1 1 102
a We estimate an error of {20% in the measurements.
b Based on an average of two measurements.
c Sauter et al. (1989).
d Sauter et al. (1992).
e Assumes a steric interference factor of 3.
binding sites on the fetuin-bound surface blocked by which is four orders of magnitude tighter than X-31
BHA, X-31 low-pH rosettes, or X-31 virus bound to solu-each binding event. We estimate a steric interference
factor of 3 based on the size of the BHA rosette and the ble trisaccharides such as a(2,3)-sialyllactose or
a(2,6)-sialyllactose, which are the sialoside constit-expected multivalent nature of the binding interaction.
Altering the steric interference factor in the range 2 to uents of fetuin (Sauter et al., 1989; Hanson et al., 1992).
This increased affinity is probably due to multivalent5 will change the association rate constant by less
than a factor of 2. The rate constants for association binding between the X-31 rosettes and the fetuin-deriv-
itized sensor surface. Consistent with this view is theand dissociation Ka and Kd and the equilibrium dissoci-
ation constant Kd derived from the analysis are shown observation that X-31 BHA does not measurably bind to
the fetuin-derivitized sensor surface (data not shown).in the second part of Table 1. The Ka of 2 1 103 M01
sec01 is lower than expected for a typical protein – On the other hand, X-31 virus binds tightly and specifi-
cally to the fetuin-derivitized sensor surface (data notligand interaction, but the Kd of 2 1 1004 sec01 is ex-
tremely slow, resulting in tight binding. X-31 rosettes shown). However, there was substantial loss of binding
after removal of the X-31 virus from the sensor surface.bind with an equilibrium dissociation constant (Kd) of
1 1 1007 M to the fetuin-derivitized sensor surface, This loss of binding could be reduced, but not eliminated,
by reducing the amount of X-31 virus bound or reducing
the time that X-31 virus was bound to the sensor surface.
These results suggest that viral neuraminidase was re-
moving sialic acid from the fetuin, resulting in reduced
binding.
DISCUSSION
Perhaps the most important feature of the SPR assay
is its small scale. A single injection requires only 80
ml of solution at a rosette concentration of as little as
100 mg/ml, so the total amount of protein required per
injection was only 8 mg for X-31 rosettes and 36 mg for
G135R rosettes. The small volumes also allow the use
of small amounts of the sialic acid derivatives or other
FIG. 4. An overlay of sensorgrams used in Kd determination. 40 synthetic inhibitors for inhibition studies; typically a
ml of X-31 BHA rosettes at concentrations of 200 mg/ml (solid circles), single inhibition curve can be obtained using less than
100 mg/ml (open squares), and 50 mg/ml (solid triangles) was in-
0.5 mg of inhibitor, assuming the inhibitor has a milli-jected over a fetuin-derivitized sensor surface at a flow rate of 5 ml/
molar dissociation constant. This assay can be used tomin. During the 7.5-min dissociation phase which followed, HBS was
injected over the sensor surface at a flow rate of 5 ml/min. screen inhibitors with only a small quantity of inhibitor,
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using the half-maximal inhibition concentration as a nation up to 100-fold better than the corresponding
monosialosides (Glick et al., 1991). Similarly, thismeasure of inhibitory effect. Although the half-maximal
inhibition concentrations do not exactly match the dis- assay may allow one to screen for inhibitors that do not
bind soluble trimers well but can inhibit the multivalentsociation constants obtained using NMR, they are
close and usually do match the expected order qualita- interaction that characterizes the binding of influenza
virus to its target cell.tively. This similarity in values must be regarded with
caution because application of the Cheng – Prusoff cor-
rection (Cheng and Prusoff, 1973) or Schild analysis ACKNOWLEDGMENTS
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